We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cepheid Expands Distribution into Latin America

By HospiMedica staff writers
Posted on 22 Apr 2004
Following the signing of multi-year distribution agreements, Cepheid (Sunnyvale, CA, USA; www.cepheid.com) has announced the company will market its SmartCycler portable laboratory system along with accessories and disposables in Mexico and Brazil.

The SmartCycler is a thermal cycler with real-time optical detection that can be used to quickly and accurately detect infectious disease agents, human genes, and industrial or environmental contamination. Cepheid signed marketing agreements with BioAgency Co. Ltd. (Sao Paulo, Brazil) and Industrias Bioselec S.A. de C.V. (Mexico City, Mexico). Both companies will provide marketing, sales, and service support for the SmartCycler product line.

"Both BioAgency and Biocelec are companies that have a well-earned reputation as quality business units that maintain high standards of customer service,” noted Ira Marks, vice president, worldwide sales & marketing, Cepheid. "These relationships will help to strongly position Cepheid's products in selected Latin American territories and will enhance Bioagency's and Bioselec's roles in the developing life science and genomic testing markets.




Related Links:
Cepheid

Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Tabletop Centrifuge
Mikro 185
New
Lab Sample Rotator
H5600 Revolver

Latest Industry News

Bio-Techne and ALZpath Partner to Advance Neurodegenerative Disease Research and Treatment

Microbiologics Acquires Diagnostic Quality Controls Manufacturer SensID

Beckman Coulter Partners with BioPorto for Global Distribution of Acute Kidney Injury NGAL Tests